Icon
+91 94997 68112
Login Register

Aggrenox - (25mg;200mg, Capsule, Extended Release)

Aspirin and Dipyridamole Boehringer Ingelheim
25mg;200mg, Capsule, Extended Release
Less Than $1000 mn
Less Than 5
More Than 5
Less Than 5
 None
More Than 5
More Than 5
Used to reduce the risk of stroke in people who have had blood clots or a "mini-stroke" (also called a transient ischemic attack or TIA)
Yes
**** (****) ***** **** ** ** ********, ****** ******** ** *** ****, *** **** *** ********* ** *** *********. ***** ********* *** ******* ******* ******* **** ** ********** ** *** ***** **** **** ****** ********** ******* ******* ** ******** *** ***** **** **** ****. ******* *** **** ********** *** *********** ******** ******** ***** ** ********* **** ***********. *** ******* ** **** ** ***** *******. **** ******** ******* ******** ** *** **, ****.
Aggrenox Patent 1
**** (****) *******
****** *******
***** *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** (****) *** \ ** ***, **** ******* ******** ******** ** *** **, ****
****** ** \ ** **** **, **** ******* **** ****** **** ********
***** ** \ ** *** **, **** ******* **** ****** **** ********
  1. ***, **** : **** ******** ********** ***** *** ****** ****** **** *****/**** ******** ******** *** ****** *******.
  2. ****, **** : ********** ***** * **** ******* **** ** ******** ***** ** ********.
  3. ***, **** : ********** & **** (****) ******* * ********** ********* ********* ** ***** **** **** ****** ********** ******* ******* ** ******** *** ***** **** **** ****.
  4. ***, **** : ******* ***** ********** ***** * ******** ** ** ******** ***** ** ******** ******** ********** ** *********** ******** ******** ***** ** ********* **** ***********.
  5. *** *, **** : ******* ******** ** ***** *** **** ** *** ****** '*** - *** **, ****.
  6. *** **, **** : ** **** ******** ** ******** ** *** ******.
  7. *** **, **** : ** **** ***** *** ****** ** ****** '***
  8. *** **, **** : ********** ********* **** *******
  9. *** **, **** : ********** ********* **** ******
  10. *** *, **** : **** ******** ******* ********.
  11. *** **, **** : ********** ********* **** *****
  12. *** **, **** : ** **** ****** *** *** ****** ** ****** '***
  13. *** **, **** : ********** ********* **** ****** *** *** ******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.